ChartingTheGlobe

  1. Home
  2. United States
  3. Research
  4. R&D by business by area

Research & development by business enterprise, pharmaceutical industry in constant PPP $ in the United States

Line
Bar
Map
Table
The research & development by business enterprise, pharmaceutical industry in constant ppp $ in the United States has reached 91,740.86 million, signifying a 6,588.28 million (7.7%) increase compared to 2020.
Download image

Full screen

Close
Data currently not available for this time and region, try a different time period
Group by:
Value Equal sized Natural
Source:
Data availability:
Regions:
40
Date range: 1987 to 2022
Points:
779
Measure:
Constant USD PPP
Similar regions to the United States Business R&D pharmaceutical in constant PPP $
China
21,406.92M
+2,773.95M
(2021)
Japan
13,542.85M
+256.56M
(2022)
Germany
6,316.45M
+137.82M
(2021)
More regions
More indicators for the United States
Government R&D in security as % of government support
40.85%
+0.74%
(2020)
Higher-education-finacing R&D financed by general university in local currency
0.00M
0.00M
(2022)
R&D financed by rest of the world in local currency
634,270.00M
+63,140.00M
(2022)
Government R&D financed by rest of the world in local currency
0.00M
0.00M
(2022)
Business R&D financed by rest of the world in local currency
619,470.00M
+62,450.00M
(2022)
Non-profit R&D growth rate
-6.04%
-2.16%
(2022)
More indicators
United States Business R&D pharmaceutical in constant PPP $ between 1987 and 2021
Period Business R&D pharmaceutical in constant PPP $ Change
2021 91,740.86M +6,588.28M
2020 85,152.58M +2,212.02M
2019 82,940.56M +10,994.60M
2018 71,945.96M +6,380.36M
2017 65,565.61M +1,394.44M
2016 64,171.17M +4,871.17M
2015 59,300.00M +2,162.62M
2014 57,137.38M +3,303.31M
2013 53,834.07M +3,553.56M
2012 50,280.51M +1,400.82M
2011 48,879.69M -4,771.58M
2010 53,651.27M +4,270.06M
2009 49,381.21M -3,837.29M
2008 53,218.49M -575.67M
2007 53,794.16M +8,764.77M
2006 45,029.39M +3,458.29M
2005 41,571.10M +2,834.00M
2004 38,737.11M +18,560.55M
2003 20,176.56M +1,876.00M
2002 18,300.56M +5,034.09M
2001 13,266.47M -3,852.94M
2000 17,119.41M -270.56M
1999 17,389.97M -189.94M
1998 17,579.91M +880.55M
1997 16,699.36M +2,746.80M
1996 13,952.56M -898.02M
1995 14,850.58M +552.48M
1994 14,298.09M +432.99M
1993 13,865.11M +1,536.75M
1992 12,328.36M +1,120.94M
1991 11,207.43M +890.18M
1990 10,317.24M +430.42M
1989 9,886.82M +1,207.14M
1988 8,679.68M +1,170.40M
1987 7,509.28M
×